![Maria Fardis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maria Fardis
Directeur/Membre du Conseil chez
CRISPR THERAPEUTICS AG
Fortune : - $ au 31/07/2026
Profil
Actuellement, Maria Fardis occupe le poste de présidente, directrice générale et directrice chez Iovance Biotherapeutics, Inc. Elle est également membre du conseil d'administration de l'Alliance for Regenerative Medicine et de Kartos Therapeutics, Inc. Dans le passé, elle a été directrice de l'exploitation chez Acerta Pharma LLC, directrice associée de la gestion de projets et de portefeuilles chez Gilead Sciences, Inc. et directrice de l'exploitation chez Acerta Pharma BV, ainsi que directrice des opérations et des alliances en oncologie chez Pharmacyclics LLC. Le Dr Fardis est titulaire d'un doctorat de l'Université de Californie, Berkeley, d'un MBA de la Golden Gate University et d'un diplôme de premier cycle de l'Université de l'Illinois à UrbanaChampaign.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Dernières actualités sur Maria Fardis
Postes actifs de Maria Fardis
| Sociétés | Poste | Début |
|---|---|---|
| CRISPR THERAPEUTICS AG | Directeur/Membre du Conseil | 09/06/2022 |
Lassen Therapeutics 1, Inc.
 Lassen Therapeutics 1, Inc. BiotechnologyHealth Technology Develops novel and best-in-class biotherapeutics | Directeur Général | 01/04/2023 |
Quanta Therapeutics, Inc.
 Quanta Therapeutics, Inc. BiotechnologyHealth Technology Develops allosteric inhibitors for RAS-driven cancers | Directeur/Membre du Conseil | - |
Lassen Therapeutics LLC
 Lassen Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company that develops and manufactures therapeutic antibody products | Directeur Général | 04/05/2023 |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Président | 19/01/2022 |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical products & distribution, pharmaceuticals and healthcare service sectors. It provides financing for buyout and growth stage capital requirements. | Private Equity Investor | 22/09/2021 |
Kartos Therapeutics, Inc.
 Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company that develops novel and targeted therapeutics | Directeur/Membre du Conseil | - |
Anciens postes connus de Maria Fardis
| Sociétés | Poste | Fin |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Directeur Général | 18/06/2021 |
Acerta Pharma LLC
 Acerta Pharma LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that specializes in drug development | Directeur des opérations | 01/03/2016 |
| ░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Maria Fardis
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
89
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical products & distribution, pharmaceuticals and healthcare service sectors. It provides financing for buyout and growth stage capital requirements. | Finance |
Golden Gate University
 Golden Gate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Health Technology |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
University of Illinois At Urbana–Champaign
 University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quanta Therapeutics, Inc.
Quanta Therapeutics, Inc. BiotechnologyHealth Technology Develops allosteric inhibitors for RAS-driven cancers | Health Technology |
Kartos Therapeutics, Inc.
Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company that develops novel and targeted therapeutics | Health Technology |
Lassen Therapeutics LLC
Lassen Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company that develops and manufactures therapeutic antibody products | Commercial Services |
Lassen Therapeutics 1, Inc.
Lassen Therapeutics 1, Inc. BiotechnologyHealth Technology Develops novel and best-in-class biotherapeutics | Health Technology |
Acerta Pharma LLC
Acerta Pharma LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that specializes in drug development | Health Technology |
